Fiscal Year 2024 KEY HIGHLIGHTS$273.9M net revenue27.5% comparable growth$203.6M adj. gross profit$40.3M Adj. Ebitda Results Events Latest Event Waldencast plc First Quarter Fiscal 2025 Earnings Call May 14, 2025 8:30 AM EDT Latest Event Waldencast plc Fourth Quarter Fiscal 2024 Earnings Call March 19, 2025 8:30 AM EDT All Events Press Releases Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthfulness March 24, 2026 Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™ March 19, 2026 All Press Releases Stock Chart Stock Information Minimum 15 minutes delayed. Source: LSEG
Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthfulness March 24, 2026
Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™ March 19, 2026